ArticlePediatric blood & cancer2015

Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.

Edwin Jousma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.